Copy For Citation
MBANYA J. C., AL-SIFRI S., ABDEL-RAHIM A., Satman I.
DIABETES RESEARCH AND CLINICAL PRACTICE, vol.109, no.2, pp.226-232, 2015 (SCI-Expanded)
-
Publication Type:
Article / Review
-
Volume:
109
Issue:
2
-
Publication Date:
2015
-
Doi Number:
10.1016/j.diabres.2015.04.030
-
Journal Name:
DIABETES RESEARCH AND CLINICAL PRACTICE
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Page Numbers:
pp.226-232
-
Keywords:
Ramadan, Diabetes, Gliclazide, GLUCOSE CONTROL, INSULIN SECRETAGOGUES, MUSLIM PATIENTS, DOUBLE-BLIND, SULFONYLUREA, VILDAGLIPTIN, SITAGLIPTIN, MANAGEMENT, MORTALITY, OUTCOMES
-
Istanbul University Affiliated:
Yes
Abstract
Aim: Hypoglycemia can be a concern for patients with type 2 diabetes when fasting during Ramadan. In this analysis, we assessed the incidence of symptomatic hypoglycemic events in fasting patients treated with gliclazide or dipeptidyl peptidase-4 (DPP-4) inhibitors.